Aptinyx Financials

Aptinyx Stock Summary

Aptinyx competes with ABVC Biopharma, CytomX Therapeutics, Assembly Biosciences, Instil Bio, and Nuvation Bio. Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx Inc. was incorporated in 2015 and is headquartered in Evanston, Illinois. Aptinyx operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 40 people.

Aptinyx Key Financial Ratios

Aptinyx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Aptinyx's current stock value. Our valuation model uses many indicators to compare Aptinyx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aptinyx competition to find correlations between indicators driving Aptinyx's intrinsic value. More Info.Aptinyx is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Aptinyx's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

If you are still planning to invest in Aptinyx check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aptinyx's history and understand the potential risks before investing.